Sofia 2 SARS Antigen+ FIA; Sofia 2 Lyme FIA

K254264 · Ortho-Clinical Diagnostics, Inc. (QuidelOrtho) · QVF · Sep 4, 2026 · Microbiology

Device Facts

Record IDK254264
Device NameSofia 2 SARS Antigen+ FIA; Sofia 2 Lyme FIA
ApplicantOrtho-Clinical Diagnostics, Inc. (QuidelOrtho)
Product CodeQVF · Microbiology
Decision DateSep 4, 2026
DecisionSESE
Submission TypeDual Track
Regulation21 CFR 866.3982
Device ClassClass 2

Regulatory Classification

Identification

The Sofia 2 SARS Antigen+ FIA is a lateral flow immunofluorescent sandwich assay used with the Sofia 2 instrument for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal swab specimens from symptomatic individuals. It is intended as an aid in the diagnosis of SARS-CoV-2 infections (COVID-19) in symptomatic individuals when tested at least twice over three days with at least 48 hours between tests.

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...